1. Home
  2. ME vs HCVI Comparison

ME vs HCVI Comparison

Compare ME & HCVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ME
  • HCVI
  • Stock Information
  • Founded
  • ME 2006
  • HCVI 2021
  • Country
  • ME United States
  • HCVI United States
  • Employees
  • ME N/A
  • HCVI N/A
  • Industry
  • ME Precision Instruments
  • HCVI Blank Checks
  • Sector
  • ME Health Care
  • HCVI Finance
  • Exchange
  • ME Nasdaq
  • HCVI Nasdaq
  • Market Cap
  • ME 168.9M
  • HCVI 176.6M
  • IPO Year
  • ME N/A
  • HCVI 2021
  • Fundamental
  • Price
  • ME $0.34
  • HCVI $10.67
  • Analyst Decision
  • ME Hold
  • HCVI
  • Analyst Count
  • ME 1
  • HCVI 0
  • Target Price
  • ME $0.47
  • HCVI N/A
  • AVG Volume (30 Days)
  • ME 2.4M
  • HCVI 52.8K
  • Earning Date
  • ME 11-06-2024
  • HCVI 01-01-0001
  • Dividend Yield
  • ME N/A
  • HCVI N/A
  • EPS Growth
  • ME N/A
  • HCVI N/A
  • EPS
  • ME N/A
  • HCVI N/A
  • Revenue
  • ME $199,188,000.00
  • HCVI N/A
  • Revenue This Year
  • ME $0.05
  • HCVI N/A
  • Revenue Next Year
  • ME $17.98
  • HCVI N/A
  • P/E Ratio
  • ME N/A
  • HCVI N/A
  • Revenue Growth
  • ME N/A
  • HCVI N/A
  • 52 Week Low
  • ME $0.29
  • HCVI $10.30
  • 52 Week High
  • ME $1.09
  • HCVI $11.47
  • Technical
  • Relative Strength Index (RSI)
  • ME 49.74
  • HCVI 61.73
  • Support Level
  • ME $0.29
  • HCVI $10.62
  • Resistance Level
  • ME $0.36
  • HCVI $10.68
  • Average True Range (ATR)
  • ME 0.02
  • HCVI 0.01
  • MACD
  • ME 0.01
  • HCVI 0.00
  • Stochastic Oscillator
  • ME 64.86
  • HCVI 91.09

About ME 23andMe Holding Co.

23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.

About HCVI Hennessy Capital Investment Corp. VI

Hennessy Capital Investment Corp VI is a shell company.

Share on Social Networks: